Top

Published in:

Open Access 01-01-2018 | Review Article

A clinical review of phototherapy for psoriasis

Authors: Ping Zhang, Mei X. Wu

Published in: Lasers in Medical Science | Issue 1/2018

Abstract

Psoriasis is an autoimmune inflammatory skin disease. In the past several decades, phototherapy has been widely used to treat stable psoriatic lesions, including trunk, scalp, arms and legs, and partial nail psoriasis. A variety of light/lasers with different mechanisms of action have been developed for psoriasis including ultraviolet B (UVB), psoralen ultraviolet A (PUVA), pulsed dye laser (PDL), photodynamic therapy (PDT), intense pulsed light (IPL), light-emitting diodes (LED), and so on. Because light/laser each has specific therapeutic and adverse effects, it is important to adequately choose the sources and parameters in management of psoriasis with different pathogenic sites, severities, and duration of the disorder. This review aims at providing most updated clinic information to physicians about how to select light/laser sources and individual therapeutic regimens. To date, UV light is primarily for stable plaque psoriasis and PDL for topical psoriatic lesions with small area, both of which are safe and effective. On the other hand, PUVA has better curative effects than UVB for managing refractory psoriasis plaques, if its side effects can be better controlled. PDL provides optimal outcomes on nail psoriasis compared with other lasers. Although the trails of low-level light/laser therapy (LLLT) are still small, the near infrared (NIR) and visible red light with low energy show promise for treating psoriasis due to its strong penetration and encouraging photobiomodulation. IPL is rarely reported for psoriasis treatment, but PDT-IPL has been found to offer a moderate effect on nail psoriasis. In brief, various phototherapies have been used either in different combinations or as monotherapy. The modality has become a mainstay in the treatment of mild-to-moderate psoriasis without systemic adverse events in today’s clinical practice.

Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, JJ W, Mehta NN, Finlay AY, Gottlieb AB (2016) Psoriasis. Nat Rev Dis Primers 2:16082CrossRefPubMed

Goldenberg G, Lanoue J, Dong J (2016) New oral therapies for psoriasis: a comprehensive review. J Clin Aesthet Dermatol 9(8):25–28PubMedPubMedCentral

Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am AcadDermatol 61(3):451–485CrossRef

Laws PM, Warren RB (2011) Ustekinumab for the treatment of psoriasis. Expert Rev Clin Immunol 7(2):155–164CrossRefPubMed

Calzavara-Pinton PG, Sala R, Arisi M, Rossi MT, Venturini M, Ortel B (2013) Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis. Br J Dermatol 169(1):130–136CrossRefPubMed

Mehta D, Lim HW (2016) Ultraviolet B phototherapy for psoriasis: review of practical guidelines. Am J ClinDermatol 17(2):125–133

Stern RS (2007) Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med 357(7):682–690CrossRefPubMed

Ahmed Asim S, Ahmed S, Us-Sehar N (2013) Psoralen-ultraviolet a treatment with psoralen-ultraviolet B therapy in the treatment of psoriasis. Pak J Med Sci 29(3):758–761PubMedPubMedCentral

Astner S, Anderson RR (2005) Treating vascular lesions. Dermatol Ther 18:267–281CrossRefPubMed

10.

Hacker SM, Rasmussen JE (1992) The effect of flash lamp-pulsed dye laser on psoriasis. Arch Dermatol 128:853–855CrossRefPubMed

11.

Ablon G (2010) Combination 830-nm and 633-nm light-emitting diode phototherapy shows promise in the treatment of recalcitrant psoriasis: preliminary findings. Photomed Laser Surg 28(1):141–146CrossRefPubMed

12.

Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR (2011) A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol 64(5):936–949CrossRefPubMed

13.

Kleinpenning MM, Smits T, Boezeman J, van de Kerkhof PC, Evers AW, Gerritsen MJ (2009) Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens. Br J Dermatol 161:1351–1356CrossRefPubMed

14.

Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Daudén E, Gisondi P, Iversen L, Kemény L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N (2011) Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 303:1–10CrossRefPubMed

15.

Samarasekera E, Sawyer L, Parnham J, Smith CH (2012) Guideline development group assessment and management of psoriasis: summary of NICE guidance. BMJ 345:e6712CrossRefPubMed

16.

Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am AcadDermatol 58(5):826–850CrossRef

17.

Neumann NJ, Mahnke N, Korpusik D, Stege H, Ruzicka T (2006) Treatment of palmoplantar psoriasis with monochromatic excimer light (308-nm) versus cream PUVA. Acta DermVenereol 86:22–24

18.

Rácz E, Prens EP, Kurek D, Kant M, de Ridder D, Mourits S, Baerveldt EM, Ozgur Z, van IJcken WF, Laman JD, Staal FJ, der v, Fits L (2011) Effective treatment of psoriasis with narrowband UVB phototherapy is linked to suppression of the IFN and Th17 pathways. J Ibvest Dermatol 131(7):1547–1558CrossRef

19.

Batycka-Baran A, Besgen P, Wolf R, Szepietowski JC, Prinz JC (2016) The effect of phototherapy on systemic inflammatory process in patients with plaque psoriasis. J Photo chem Photo biol B 161:396–401CrossRef

20.

Białecka M, Ostasz R, Kurzawski M, Klimowicz A, Fabiańczyk H, Bojko P, Dziedziejko V, Safranow K, Machoy-Mokrzyńska A, Droździk M (2016) IL17A and IL17F gene polymorphism association with psoriasis risk and response to treatment in a polish population. Dermatology 232(5):592–596CrossRefPubMed

21.

Gui J, Gober M, Yang X, Katlinski KV, Marshall CM, Sharma M, Werth VP, Baker DP, Rui H, Seykora JT, Fuchs SY (2016) Therapeutic elimination of the type 1 interferon receptor for treating psoriatic skin inflammation. J Invest Dermatol 136(10):1990–2002CrossRefPubMedPubMedCentral

22.

Zhang D, Chen Y, Chen L, Yang R, Wang L, Liu W, Zhai Z, Shen Z (2016) Ultraviolet irradiation promotes FOXP3 transcription via p53 in psoriasis. Exp Dermatol 25(7):513–518CrossRefPubMed

23.

Metwally D, Sayed K, Abdel Hay R, Rashed L (2015) Reduction in tissue plasmin: a new mechanism of action of narrowband ultraviolet B in psoriasis. Clin Exp Dermatol 40(4):416–420CrossRefPubMed

24.

Chowdhari S, Saini N (2014) Hsa-miR-4516 mediated downregulation of STAT3/CDK6/ UBE2N plays a role in PUVA induced apoptosis in keratinocytes. J Cell Physiol 229(11):1630–1638CrossRefPubMed

25.

Sevrain M, Richard MA, Barnetche T, Rouzaud M, Villani AP, Paul C, Beylot-Barry M, Jullien D, Aractingi S, Aubin F, Joly P, Le Maitre M, Cantagrel A, Ortonne JP, Misery L (2014) Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion. J Eur Acad Dermatol Venereol 28(Suppl 5):13–16CrossRefPubMed

26.

Weatherhead SC, Farr PM, Reynolds NJ (2013) Spectral effects of UV on psoriasis. PhotochemPhotobiol Sci 12(1):47–53CrossRef

27.

Doppalapudi S, Jain A, Chopra DK, Khan W (2017) Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Eur J Pharm Sci 96:515–529CrossRefPubMed

28.

Höölzle E (2011) Phototherapy and photochemotherapy in childhood psoriasis. Expert Rev Dermatol 6:4CrossRef

29.

Karsai S, Roos S, Hammes S, Raulin C (2007) Pulsed dye laser: what’s new in non-vascular lesions? J Eur Acad Dermatol Venereol 21(7):877–890CrossRefPubMed

30.

Erceg A, de Jong EM, van de Kerkhof PC, Seyger MM (2013) The efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic review. J Am Acad Dermatol 69(4):609–615CrossRefPubMed

31.

De Leeuw J, Van Lingen RG, Both H, Tank B, Nijsten T, Martino Neumann HA (2009) A comparative study on the efficacy of treatment with 585nm pulsed dye laser and ultraviolet B-TL01 in plaque type psoriasis. Dermatol Surg 35(1):80–91PubMed

32.

Taibjee SM, Cheung ST, Laube S, Lanigan SW (2005) Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis. Br J Dermatol 153:960–966CrossRefPubMed

33.

Ilknur T, Akarsu S, Aktan S, Ozkan S (2006) Comparison of the effects of pulsed dye laser, pulsed dye laser + salicylic acid, and clobetasole propionate + salicylic acid on psoriatic plaques. Dermatol Surg 32(1):49–55CrossRefPubMed

34.

Rácz E, de Leeuw J, Baerveldt EM, Kant M, Neumann HA, van der Fits L, Prens EP (2010) Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis. Lasers Surg Med 42(3):201–210CrossRefPubMed

35.

Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM (2007) Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization. J Dermatolog Treat 18(1):32–39CrossRefPubMed

36.

Liu A, Moy RL, Ross EV, Hamzavi I, Ozog DM (2012) Pulsed dye laser and pulsed dye laser-mediated photodynamic therapy in the treatment of dermatologic disorders. Dermatol Surg 38(3):351–366CrossRefPubMed

37.

Bouzari N, Davis SC, Nouri K (2007) Laser treatment of keloids and hypertrophic scars. Int J Dermatol 46(1):80–88CrossRefPubMed

38.

Kuo YR, Wu WS, Jeng SF, Wang FS, Huang HC, Lin CZ, Yang KD (2005) Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg Med 36(1):38–42CrossRefPubMed

39.

Nouri K, Elsaie ML, Vejjabhinanta V, Stevens M, Patel SS, Caperton C, Elgart G (2010) Comparison of the effects of short- and long-pulse durations when using a 585-nm pulsed dye laser in the treatment of new surgical scars. Lasers Med Sci 25(1):121–126CrossRefPubMed

40.

Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR (2012) The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng 40(2):516–533CrossRefPubMed

41.

Avci P, Gupta A, Sadasivam M, Vecchio D, Pam Z, Pam N, Hamblin MR (2013) Low-level laser (light) therapy (LLLT)in skin: stimulating, healing, restoring. SeminCutan Med Surg 32(1):41–52

42.

Pfaff S, Liebmann J, Born M, Merk HF, von Felbert V (2015) Prospective randomized long-term study on the efficacy and safety of UV-free blue light for treating mild psoriasis vulgaris. Dermatology 231(1):24–34CrossRefPubMed

43.

Weinstabl A, Hoff-Lesch S, Merk HF, von Felbert V (2011) Prospective randomized study on the efficacy of blue light in the treatment of psoriasis vulgaris. Dermatol 223:251–259CrossRef

44.

Niu T, Tian Y, Ren Q, Wei L, Li X, Cai Q (2014) Red light interferes in UVA-induced photoaging of human skin fibroblast cells. Photochem Photobiol 90(6):1349–1358CrossRefPubMed

45.

Kwon HH, Lee JB, Yoon JY, Park SY, Ryu HH, Park BM, Kim YJ, Suh DH (2013) The clinical and histological effect of home-use, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial. Br J Dermatol 168:1088–1094CrossRefPubMed

46.

Chen AC, Arany PR, Huang YY, Tomkinson EM, Sharma SK, Kharkwal GB, Saleem T, Mooney D, Yull FE, Blackwell TS, Hamblin MR (2011) Low level laser therapy activates NF-jB via generation of reactive oxygen species in mouse embryonic fibroblasts. PLoS One 6(7):e22453CrossRefPubMedPubMedCentral

47.

Niu T, Tian Y, Cai Q, Ren Q, Wei L (2015) Red light combined with blue light irradiation regulates proliferation and apoptosis in skin keratinocytes in combination with low concentrations of curcumin. PLoS One 10(9):e0138754CrossRefPubMedPubMedCentral

48.

Huang YY, Sharma SK, Carroll J, Hamblin MR (2011) Biphasic dose response in low level light therapy an update. Dose Response 9(4):602–618CrossRefPubMedPubMedCentral

49.

Wong-Riley MT, Liang HL, Eells JT, Chance B, Henry MM, Buchmann E, Kane M, Whelan HT (2005) Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J Biol Chem 280(6):4761–4771CrossRefPubMed

50.

Zhang Q, Dong T, Li P, Wu MX (2016) Noninvasive low-level laser therapy for thrombocytopenia. Sci Transl Med 8(349):349 ra101CrossRef

51.

Peplow PV, Chung TY, Ryan B, Baxter GD (2011) Laser photobiomodulation of gene expression and release of growth factors and cytokines from cells in culture: a review of human and animal studies. Photomed Laser Surg 29(5):285–304CrossRefPubMed

52.

Dong T, Zhang Q, Hamblin MR, MX W (2015) Low-level light in combination with metabolic modulators for effective therapy of injured brain. J Cereb Blood Flow Metab 35(9):1435–1444CrossRefPubMedPubMedCentral

53.

Zhang Q, Zhou C, Hamblin MR, MX W (2014) Low-level laser therapy effectively prevents secondary brain injury induced by immediate early responsive gene X-1 deficiency. J Cereb Blood Flow Metab 34(8):1391–1401CrossRefPubMedPubMedCentral

54.

Keyal U, Bhatta AK, Wang XL (2016) Photodynamic therapy for the treatment of different severity of acne: a systematic review. Photodiagn Photodyn Ther 14:191–199CrossRef

55.

Kim M, Jung HY, Park HJ (2015) Topical PDT in the treatment of benign skin diseases: principles and new applications. Int J Mol Sci 16(10):23259–23278CrossRefPubMedPubMedCentral

56.

Byun JY, Lee GY, Choi HY, Myung KB, Choi YW (2011) The expressions of TGF-β(1) and IL-10 in cultured fibroblasts after ALA-IPL photodynamic treatment. Ann Dermatol 23(1):19–22CrossRefPubMedPubMedCentral

57.

Calzavara-Pinton PG, Rossi MT, Aronson E, Sala R (2013) Italian group for photodynamic therapy. A retrospective analysis of real life practice of off label photodynamic therapy using methylaminolevulinate MAL-PDT in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications. Photochem Photobiol Sci 12(1):148–157CrossRefPubMed

58.

Le Pillouer-Prost A, Cartier H (2016) Photodynamic photorejuvenation: a review. Dermatol Surg 42(1):21–30CrossRefPubMed

59.

Tawfik AA (2014) Novel treatment of nail psoriasis using the intense pulsed light: a one-year follow-up study. Dermatol Surg 40(7):763–768PubMed

60.

Schons KR, Beber AA, Beck Mde O, Monticielo OA (2015) Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features. An Bras Dermatol 90(3):314–319CrossRefPubMedPubMedCentral

61.

Fernández-Guarino M, Harto A, Sánchez-Ronco M, García-Morales I, Jaén P (2009) Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study. J Eur Acad Dermatol Venereol 23:891–895CrossRefPubMed

62.

Treewittayapoom C, Singvahanont P, Chanprapaph K, Haneke E (2012) The effect of different pulse durations in the treatment of nail psoriasis with 595-nm pulsed dye laser: a randomized, double-blind, intrapatient left-to-right study. J Am Acad Dermatol 66:807–812CrossRefPubMed

63.

Al-Mutairi N, Noor T, Al-Haddad A (2014) Single blinded left-to-right comparison study of excimer laser versus pulsed dye laser for the treatment of nail psoriasis. Dermatol Ther (Heidelb) 4:197–205CrossRef

64.

Stern DK, Creasey AA, Quijije J, Lebwohl MG (2011) UV-A and UV-B penetration of normal human cadaveric fingernail plate. Arch Dermatol 147:439–441CrossRefPubMed

65.

Seebode C, Lehmann J, Emmert S (2016) Photocarcinogenesis and skin cancer prevention strategies. Anticancer Res 36(3):1371–1378PubMed

66.

Holme SA, Anstey AV (2004) Phototherapy and PUVA photochemotherapy in children. Photodermatol Photoimmunol Photomed 20:69–75CrossRefPubMed

Title: A clinical review of phototherapy for psoriasis
Authors: Ping Zhang
Mei X. Wu
Publication date: 01-01-2018
Publisher: Springer London
Published in: Lasers in Medical Science / Issue 1/2018
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-017-2360-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

A clinical review of phototherapy for psoriasis

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Analysis of choroidal thickness in ocular hypertensive patients using enhanced depth imaging optical coherence tomography

cDNA microarray analysis of human keratinocytes cells of patients submitted to chemoradiotherapy and oral photobiomodulation therapy: pilot study

A study on the clinical characteristics of treating nevus of Ota by Q-switched Nd:YAG laser

Treatment of striae distensae with non-ablative fractional laser: clinical and in vivo microscopic documentation of treatment efficacy

Sub-ablative Er,Cr:YSGG laser irradiation under all-ceramic restorations: effects on demineralization and shear bond strength

Laser photobiomodulation in pressure ulcer healing of human diabetic patients: gene expression analysis of inflammatory biochemical markers